Who Owns agilon health Company?

agilon health Bundle

Get Full Bundle:

	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10
	SWOT	$15	$10

TOTAL:

ADD TO CART

Who owns agilon health?

Understanding agilon health's ownership is key to grasping its strategic path and stakeholder influence. The company's journey includes an IPO in April 2021, opening its doors to public investment.

agilon health, established in 2016, aims to empower primary care physicians in senior healthcare through value-based care. By December 31, 2024, it generated $6.06 billion in revenue, serving about 659,000 members.

Who owns agilon health?

agilon health was established in 2016 by Ronald A. Williams and Veeral Desai, with Williams also serving as Executive Chairman. The company officially incorporated in April 2017. Its early development and ownership structure were significantly influenced by the private equity firm Clayton Dubilier & Rice (CD&R).

Founding Team Ronald A. Williams and Veeral Desai founded agilon health in 2016. Incorporation Date The company was incorporated in April 2017. Key Early Investor Clayton Dubilier & Rice (CD&R) was a significant early backer. Pre-IPO Ownership A CD&R investment fund held approximately 69% of shares before the IPO. Post-IPO Ownership Estimate CD&R's stake was projected to be around 58% after the IPO. Ownership Model This reflects a common model for high-growth healthcare technology firms.

The early ownership of agilon health was heavily concentrated, primarily due to the substantial investment from Clayton Dubilier & Rice. This private equity backing provided the essential capital and strategic direction needed for the company's initial growth phase. While specific equity distributions among individual founders at the company's inception are not publicly disclosed, the significant control exercised by CD&R highlights a common pattern of institutional investor dominance in the formative stages of rapidly expanding healthcare technology ventures. Understanding this early ownership structure is key to grasping the company's trajectory and its subsequent public offering. For a deeper dive into the competitive environment, explore the Competitors Landscape of agilon health.

Founders and Early Investment

agilon health's foundation in 2016 was a strategic move supported by significant private equity capital, shaping its initial ownership landscape.

• Founders: Ronald A. Williams and Veeral Desai
• Incorporation: April 2017
• Primary Early Investor: Clayton Dubilier & Rice (CD&R)
• CD&R's Pre-IPO Stake: Approximately 69%
• CD&R's Post-IPO Stake Estimate: Around 58%

agilon health SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

agilon health transitioned to a publicly traded entity on April 15, 2021, with its shares listed on the New York Stock Exchange under the ticker AGL. The company's initial public offering successfully raised approximately $1.07 billion in gross proceeds, a figure that later grew to about $1.233 billion after underwriters exercised their options for additional shares.

Following its public debut, agilon health's ownership structure is predominantly characterized by significant institutional investment. As of June 2025, institutional investors collectively held a substantial portion of the company's shares, reflecting strong confidence in its operational model. Key institutional stakeholders include Clayton, Dubilier & Rice, LLC, which held 100,000,000 shares, representing 24.13% of the company's stock. Other major institutional investors as of recent filings include Morgan Stanley, Capital World Investors, Fmr Llc with a 9.4% passive stake as of June 30, 2025, Vanguard Group Inc, and BlackRock, Inc. The influence of these large investment entities suggests that strategic decisions are often shaped by their collective interests. Founders also maintain notable stakes, with Ronald A. Williams holding 3,675,257 shares, equating to 4.1% ownership as of May 2025, underscoring a continued commitment from the company's leadership. Understanding who owns agilon health is crucial for grasping the dynamics of its governance and future direction, as detailed in analyses of its Revenue Streams & Business Model of agilon health.

Key Ownership Insights

Institutional investors are the primary holders of agilon health stock, indicating significant external confidence.

• Clayton, Dubilier & Rice, LLC is the largest single shareholder.
• Founders, like Ronald A. Williams, retain substantial ownership.
• The high institutional ownership suggests a strong influence on strategic decisions.
• The company's public listing in 2021 marked a significant shift in its ownership structure.

agilon health PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

The current Board of Directors for agilon health is instrumental in guiding the company's strategic direction and governance. Key members include Ronald A. Williams, who serves as Executive Chairman and co-founder, and Ravi Sachdev, Founder and Vice Chairman. Other directors are Silvana Battaglia, Sharad Mansukani, M.D., Diana L. McKenzie, Karen McLoughlin, and William Wulf, M.D. The significant involvement of Ronald A. Williams as an operating advisor to Clayton Dubilier & Rice (CD&R) and Ravi Sachdev as a healthcare partner at CD&R highlights the deep connection between the company's leadership and its major early investor.

agilon health operates under a standard one-share-one-vote structure for its common stock, meaning each share of common stock carries a single vote. This system ensures that voting power is directly proportional to the number of shares held, without any preferential voting rights or dual-class share structures that could concentrate control. While specific details on recent proxy fights or activist investor actions are not readily available, the significant presence of institutional investors suggests they hold substantial influence over critical corporate decisions, including the election of board members and executive compensation policies. Understanding the Target Market of agilon health can provide further context on the company's strategic positioning and stakeholder interests.

Voting Power and Influence

The voting structure at agilon health is designed for straightforward representation based on share ownership.

• One share equals one vote for common stock.
• No dual-class share structures exist.
• Institutional investors wield considerable voting influence.
• Decisions on director elections and compensation are subject to shareholder votes.

agilon health Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

Recent developments at agilon health have significantly reshaped its leadership and operational outlook. On August 4, 2025, Steven Sell stepped down from his roles as President, CEO, and Director. Ronald A. Williams, a co-founder and the Board Chairman since 2017, assumed the position of Executive Chairman, with an Office of the Chairman established to manage interim responsibilities during the search for a new CEO.

Institutional investors maintain a dominant presence in agilon health's ownership structure, holding approximately 96.98% of the company's shares as of May 2025. While mutual fund holdings saw a slight decrease from 78.49% in December 2024 to 76.10% by May 2025, the overall institutional stake remains robust. This period has also seen a considerable decline in the company's stock price, with a drop of 73.64% between August 21, 2024, and August 20, 2025, moving from $4.59 to $1.21 per share. This performance trend may reflect market responses to the company's recent strategic adjustments, including the withdrawal of its full-year 2025 guidance following its second-quarter earnings report.

Leadership Transition

Following Steven Sell's departure, Ronald A. Williams now serves as Executive Chairman. An Office of the Chairman is managing operations during the CEO search.

Stock Performance and Guidance Withdrawal

The company's stock experienced a significant decline of 73.64%. Additionally, full-year 2025 guidance was withdrawn after the Q2 earnings report.

Ownership Stability

Institutional holdings remain high at approximately 96.98% as of May 2025. Mutual fund ownership has shown minor fluctuations within this period.

Business Growth Amidst Challenges

Despite market challenges, agilon health expanded its network in 2025, partnering with over 3,000 primary care physicians. This growth aligns with the company's focus on its core business, as detailed in Mission, Vision & Core Values of agilon health.

agilon health Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔